ClassID:

112301

C12N2830/48 - page 2 - CPC Classification

Classification description:

Vector systems having a special element relevant for transcription regulating transport or export of RNA, e.g. RRE, PRE, WPRE, CTE

Recent Application in this class:
#301
20080134352
2008-06-05

Method for producing transgenic rats

#302
20080131930
2008-06-05

Means and methods for regulating gene expression

#303
20080075740
2008-03-27

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

#304
20080075737
2008-03-27

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor

#305
20080064106
2008-03-13

Lentiviral LTR-deleted vector

#306
20080021207
2008-01-24

Lentiviral packaging constructs

#307
20080003682
2008-01-03

Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell

#308
20080003658
2008-01-03

Method for expression of small antiviral RNA molecules within a cell

#309
20070289029
2007-12-13

Means and methods for producing a stabilized cell of interest

#310
20070249043
2007-10-25

Adenoviral expression vectors

#311
20070207546
2007-09-06

Bovine immunodeficiency virus (BIV) based vectors

#312
20070196922
2007-08-23

Methods and compositions relating to restricted expression lentiviral vectors and their applications

#313
20070179113
2007-08-02

GM-CSF gene therapy for Crohn's disease using an improved regulated expression system

#314
20070141706
2007-06-21

Adenovirus packaging cell lines

#315
20070134767
2007-06-14

Hiv-dependent expression constructs and uses therefor

#316
20070036760
2007-02-15

Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor

#317
20070031921
2007-02-08

Potent combinations of mRNA transport elements

#318
20070025970
2007-02-01

Vector system

#319
20070010017
2007-01-11

Lentiviral packaging constructs

#320
20070003518
2007-01-04

Raav vector-based compositions and methods for the prevention and treatment of mammalian diseases

#321
20060281703
2006-12-14

Treatment of disease using an improved regulated expression system

#322
20060239972
2006-10-26

Adiponectin gene therapy

#323
20060210538
2006-09-21

Use of apotosis inhibiting compounds in degenerative neurological disorders

#324
20060200869
2006-09-07

Lentiviral vectors carrying synthetic bi-directional promoters and uses thereof

#325
20060177934
2006-08-10

Lentiviral LTR-deleted vector

#326
20060160220
2006-07-20

Retroviral vectors with introns

#327
20060051331
2006-03-09

Optimization of transgene expression in mammalian cells

#328
20060024829
2006-02-02

Adenovirus packaging cell lines

#329
20060024279
2006-02-02

Retroviral vectors

#330
20060019395
2006-01-26

Lentiviral vectors and uses thereof

#331
20060019394
2006-01-26

Bovine immunodeficiency virus (BIV) based vectors

#332
20060019393
2006-01-26

Minimal lentiviral vector system

#333
20060003416
2006-01-05

Means and methods for producing a protein through chromatin openers that are capable of rendering chromatin more accessible to transcription factors

#334
20050261234
2005-11-24

GFAP-based gene therapy for treatment of retinal diseases

#335
20050251872
2005-11-10

Lentiviral vectors, related reagents, and methods of use thereof

#336
20050238629
2005-10-27

Lentiviral LTR-deleted vector

#337
20050221429
2005-10-06

Host cells containing multiple integrating vectors comprising an amplifiable marker

#338
20050214906
2005-09-29

Means and methods for regulating gene expression

#339
20050208660
2005-09-22

Bovine immunodeficiency virus (BIV) based vectors

#340
20050193433
2005-09-01

Compositions and methods of modulating cholesterol metabolism

#341
20050148078
2005-07-07

Bovine immunodeficiency virus (BIV) based vectors

#342
20050148077
2005-07-07

Bovine immunodeficiency virus (BIV) based vectors

#343
20050136539
2005-06-23

Reversible immortalization of human renal proximal tubular epithelial cells

#344
20050136050
2005-06-23

Bispecific antibodies

#345
20050124068
2005-06-09

Hepatocellular carcinoma specific promoter and uses thereof

#346
20050100952
2005-05-12

Host cells containing multiple integrating vectors

#347
20050079616
2005-04-14

Method of transducing ES cells

#348
20050060762
2005-03-17

Expression vectors

#349
20050042721
2005-02-24

Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site

#350
20050026157
2005-02-03

Use of chimeric nucleases to stimulate gene targeting

#351
20050026149
2005-02-03

Nucleic acid constructs capable of high effeciency delivery of polynucleotides into dna containing organelles and methods of utilizing same

#352
20050014166
2005-01-20

Compositions and systems for the regulation of genes

#353
20050009186
2005-01-13

Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site

#354
20050003545
2005-01-06

Adenovirus packaging cell lines

#355
20050003506
2005-01-06

Adenoviral E1A/E1B complementing cell line

#356
20050003482
2005-01-06

Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site

#357
20050002907
2005-01-06

Vector system

#358
17198017
2022-02-08

Combination vectors and methods for treating cancer

#359
10243817
2016-02-23

Method for producing transgenic animals